本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

武田製藥

15.38
+0.05500.36%
成交量:32.82萬
成交額:505.03萬
市值:485.28億
市盈率:37.14
高:15.43
開:15.37
低:15.35
收:15.32
資料載入中...
2024/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/31

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/28

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/06/26

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/04/10

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/01

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/05

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/25

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]